IFNB1 and acute myeloid leukemia: Although TRAIL has previously been shown to be induced in pDCs [22, 23], the stronger effect of R848 on IFNβ as well as the known insensitivity of AML cells to TRAIL-mediated killing [24–26] led us to focus on IFNβ.